Trial Profile
Phase II study to evaluate the efficacy of fractionated stereotactic body radiotherapy and gemcitabine/erlotinib chemotherapy for unresectable locally advanced pancreatic cancer.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Erlotinib (Primary) ; Gemcitabine (Primary) ; Fluorouracil
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 12 Sep 2011 New trial record